Better Therapeutics (BTTX) Financial Statements

168 Followers

Better Therapeutics Financial Overview

Better Therapeutics's market cap is currently $5.43K. The company's EPS TTM is $; its P/E ratio is ―; Better Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 8.00K	$ 18.00K
Gross Profit	$ -2.73M	$ -1.62M	$ -674.00K	$ -880.00K
Operating Income	$ -38.26M	$ -30.56M	$ -6.32M	$ -5.77M
EBITDA	$ -38.21M	$ -38.68M	$ -6.06M	$ -5.70M
Net Income	$ -39.76M	$ -40.34M	$ -6.39M	$ -5.79M
Balance Sheet
Cash & Short-Term Investments	$ 15.74M	$ 40.57M	$ 123.00K	$ 757.00K
Total Assets	$ 22.94M	$ 50.96M	$ 6.39M	$ 4.88M
Total Debt	$ 14.88M	$ 9.51M	$ 640.00K	$ 5.00M
Net Debt	$ -860.00K	$ -31.06M	$ 517.00K	$ 4.24M
Total Liabilities	$ 23.84M	$ 14.24M	$ 13.14M	$ 5.49M
Stockholders' Equity	$ -899.00K	$ 36.72M	$ -6.76M	$ -605.00K
Cash Flow
Free Cash Flow	$ -30.11M	$ -31.89M	$ -8.08M	$ -8.95M
Operating Cash Flow	$ -28.93M	$ -30.82M	$ -5.77M	$ -6.22M
Investing Cash Flow	$ -1.18M	$ -1.07M	$ -2.31M	$ -2.74M
Financing Cash Flow	$ 5.28M	$ 72.33M	$ 7.45M	$ 8.70M

Currency in USD

Better Therapeutics Earnings and Revenue History

Income Statement >

Better Therapeutics Debt to Assets

Balance Sheet >

Better Therapeutics Cash Flow

Cash Flow >

Better Therapeutics Forecast EPS vs Actual EPS

Earnings >